AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
AJPB® The American Journal of Pharmacy Benefits® November 2024
AJPB® August 2023
AJPB® August 2022
AJPB November 2020
Volume: 1
Issue: 1
AJPB July 2019
Volume: 10
Issue: 1
January/February 2018
Volume: 10
Issue: 1
November/December 2017
Volume: 9
Issue: 6
September/October 2017
Volume: 9
Issue: 5
July/August 2017
Volume: 9
Issue: 4
May/June 2017
Volume: 9
Issue: 3
March/April 2017
Volume: 9
Issue: 2
January/February 2017
Volume: 9
Issue: 1
November/December 2016
Volume: 8
Issue: 6
September/October 2016
Volume: 8
Issue: 5
July/August 2016
Volume: 8
Issue: 4
May/June 2016
Volume: 8
Issue: 3
March/April 2016
Volume: 8
Issue: 2
January/February 2016
Volume: 8
Issue: 1
November/December 2015
Volume: 12
Issue: 11
September/October 2015
Volume: 7
Issue: 5
July/August 2015
Volume: 7
Issue: 4
May/June 2015
Volume: 7
Issue: 3
March/April 2015
Volume: 7
Issue: 2
January/February 2015
Volume: 7
Issue: 1
November/December 2014
Volume: 6
Issue: 6
September/October 2014
Volume: 6
Issue: 5
July/August 2014
Volume: 6
Issue: 4
May/June 2014
Volume: 6
Issue: 3
March/April 2014
Volume: 6
Issue: 2
January/February 2014
Volume: 6
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
Enfortumab Vedotin Plus Pembrolizumab Shows Promise as a Platinum-Free Option in Earlier Bladder Cancer
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
FDA Approves Amivantamab and Hyaluronidase-lpuj, Revolutionizing Lung Cancer Treatment With 5-Minute Subcutaneous Delivery
4
Updates in Treatment of Unresectable Hepatocellular Carcinoma
5